Home / About Novasep / Media & Events / Press releases

Press releases

Novasep selected to commercially biomanufacture Celladon’s Mydicar API

17 Feb 2015

Novasep, a leading supplier of services and technologies for the life sciences industry, today announces that it has entered into an agreement with Celladon, a clinical-stage biotechnology company. Novasep will prepare to supply the drug substance for MYDICAR®.


Novasep opens new office in Thailand

15 Dec 2014

Novasep’s extended presence in South East Asia strengthens the company’s ability to address growing needs in the region’s food and feed markets.


Novasep and partner Nilsan Nishotech to install the first continuous chromatography system at Laurus Labs

13 Nov 2014

Novasep Varicol high-performance continuous chromatography technology brings productivity gains in an Indian-based API commercial production.



Novasep passes FDA inspections on two sites

22 Jul 2014

Novasep wins approval to produce new molecular entity for US market.


Novasep-MIE consortium to construct the first sorbitol production plant in Vietnam

17 Jun 2014

The plant will enable Vietnam to domestically produce sorbitol, a sugar substitute it currently imports.


Novasep’s EUR 4 million plant extension for commercial ADC payload manufacturing now commissioned

15 May 2014

The new Highly Potent API (HPAPI) manufacturing capacity at the Le Mans facility will boost Novasep’s ability to meet customer demand for producing anti-cancer therapies.




Novasep attracts top talent to complete its executive team

16 Jan 2014

Thierry Van Nieuwenhove, a seasoned CMO top executive, joins Novasep as president of the Synthesis Business Unit.


You can continue visiting and select more documents or directly download the one you selected.